AG2R La Mondiale Gestion d'Actifs’s Vertex Pharmaceuticals VRTX Stock Holding History

AG2R La Mondiale Gestion d'Actifs’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.62M	Buy	11,324 +943	+9%	+$418K	0.2%	93
2026 Q1	$4.64M	Buy	10,381 +6	+0.1%	+$2.8K	0.21%	93
2025 Q4	$4.7M	Buy	10,375 +587	+6%	+$253K	0.21%	93
2025 Q3	$4.36M	Hold	9,788	–	–	0.22%	94
2025 Q2	$4.36M	Buy	9,788 +187	+2%	+$86.2K	0.22%	94
2025 Q1	$4.24M	Buy	+9,601	New	+$4.47M	0.23%	91

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

CTB

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

AG2R La Mondiale Gestion d'Actifs's VRTX Position: Q2 2026 in Review

AG2R La Mondiale Gestion d'Actifs increased its Vertex Pharmaceuticals (VRTX) stake by 9.1% in Q2 2026, buying an estimated $418K and bringing the position to 11,324 shares worth $5.62M. The position accounts for 0.2% of the portfolio, ranked #93.

AG2R La Mondiale Gestion d'Actifs first reported a position in VRTX in Q1 2025 and has held it in 6 quarters since. 414 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

AG2R La Mondiale Gestion d'Actifs held 11,324 shares of Vertex Pharmaceuticals worth $5.62M as of Q2 2026.
AG2R La Mondiale Gestion d'Actifs bought 943 Vertex Pharmaceuticals shares in Q2 2026, an estimated $418K.
Vertex Pharmaceuticals made up 0.2% of AG2R La Mondiale Gestion d'Actifs's portfolio in Q2 2026, its #93 holding.
AG2R La Mondiale Gestion d'Actifs first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
414 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on AG2R La Mondiale Gestion d'Actifs's 13F filing for Q2 2026, filed 23 Jul 2026.